查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466240

經皮給藥系統市場：按類型、應用和最終用戶分類 - 全球預測 2024-2030

Transdermal Drug Delivery System Market by Type (Transdermal Patches, Transdermal Semisolids), Application (Cardiovascular Diseases, Central Nervous System Disorders, Hormonal Applications), End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年經皮系統市場規模為69.8億美元，2024年達73.2億美元，預計2030年將達到98.7億美元，複合年成長率為5.06%。

經皮藥物傳遞包括促進藥物透過皮膚受控釋放的治療方法的製造、分配和應用。與傳統的口服或靜脈給藥相比，這種創新方法具有許多優點，包括提高患者依從性、減少副作用和改善藥物動力學特徵。 TDDS 包括多種​​技術，包括被動擴散系統、離子電滲透療法、微針和超音波介導技術。隨著人口老化的加劇和慢性病的流行，需要更實用、方便的給藥方法。此外，奈米技術和材料科學的進步使得複雜的經皮吸收貼片的開發成為可能，這些貼片可以在生物膜上提供優異的藥物滲透性，而不會對患者造成刺激或不適。然而，與製造複雜的經皮系統相關的高開發成本和產品召回可能會對它們在醫療保健中的使用產生負面影響。此外，先進的藥物傳遞載體已顯示出提高水溶性藥物的生物有效性和溶解度並實現更有效的經皮藥物發行策略的巨大潛力。

主要市場統計
基準年[2023] 69.8億美元
預測年份 [2024] 73.2億美元
預測年份 [2030] 98.7億美元
複合年成長率（%） 5.06%

經皮吸收貼片的持續監管和政府核准

經皮吸收貼片是一種塗有黏合劑的藥貼，旨在在較長時間內透過皮膚輸送特定劑量的藥物並進入血液。與傳統的口服和腸胃外給藥系統相比，它具有多種優勢，包括提高患者依從性、減少副作用和控制釋放。有載藥貼劑、基質貼片、微針貼片、儲庫膜貼片等，依醫療要求使用。經皮吸收貼片之所以受到青睞，主要是因為其非侵入性和易於使用。適合吞嚥錠劑有困難或有胃腸道問題影響藥物吸收的患者。經皮固態藥物包括含有經由皮膚吸收進入體循環的藥物的凝膠劑、乳霜劑和軟膏劑。這些劑型的優點包括易於使用和去除、對特定病症進行局部治療而無全身副作用以及配方彈性。經皮貼片具有控制釋放機制，與半固態製劑相比，藥物釋放更穩定。此外，貼片比固態製劑更好地黏附在皮膚表面，因此凝膠和乳霜必須經常重新塗抹。

應用範例：心血管疾病治療中對微創給藥系統的需求

經皮給藥系統是治療心絞痛、高血壓等心血管疾病的首選方法，因為其副作用較少，並且可以維持血漿中藥物濃度恆定。硝酸甘油貼片廣泛用於心絞痛患者，無需頻繁口服即永續緩解症狀。 TDDS 還可以透過保持藥物濃度恆定來有效治療中樞神經系統疾病，例如帕金森氏症和阿茲海默症。連續給藥可最大限度地減少口服藥物觀察到的波動，這種波動可能導致突破性症狀和副作用。 TDDS 的荷爾蒙用途包括避孕、荷爾蒙補充療法(HRT) 和睪固酮替代療法。經皮吸收貼片具有維持荷爾蒙水平穩定、減少副作用、提高病患依從性的優點。經皮系統可以將止痛藥長時間直接輸送到受影響的區域，且全身副作用最小，使其成為治療慢性疼痛（包括與肌肉骨骼疾病和癌症相關的疼痛）的理想選擇。經皮雌激素療法對於停經後婦女的更年期症狀和骨質疏鬆症治療的荷爾蒙補充療法至關重要。

最終使用者：由於首選自我給藥，因此需要可以在家庭護理環境中實施的藥物輸送系統。

經皮給藥系統在某些創新診所中用於護膚，並被引入更有效的醫療系統中。隨著人們對藥物傳遞的了解越來越深入，以及醫生、工程師和科學家不斷推進技術的進步，基於超音波的經皮給藥平台有望向臨床應用邁進一步。臨床影響依賴安全有效給藥的經皮給藥給藥系統，該系統成本低、易於使用，並且可以在家中自行給藥。經皮給藥最近受到歡迎，因為其獨特和有利的特性在醫院環境中治療多種疾病方面比傳統給藥途徑具有未來優勢。醫院和診所服務於農村地區，尤其是老年患者。這些藥劑師幫助那些藥物交互作用高風險或因無法控制病情而出現併發症的患者。

區域洞察

經皮給藥市場正在美洲發展成為一個新興市場，那裡的醫療基礎設施和研發活動都很完善。美洲的監管機構確保在核准新產品時遵守標準指南，從而促進創新經皮技術的發展。在亞太地區，可支配收入的增加、人口老化以及對高效治療的需求正在推動對先進醫療技術的需求。在歐洲、中東和非洲地區，由於製藥業的存在、醫療保健支出的增加以及經皮系統製造能力的快速擴張，經皮給藥系統市場正在成長。此外，個人化醫療和標靶治療的日益普及預計將進一步普及針對特定患者群體和疾病狀態普及客製化的 TDDS 系統。

FPNV定位矩陣

FPNV定位矩陣對於評估經皮給藥系統市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對經皮給藥系統市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.經皮給藥系統市場的市場規模與預測是多少？

2.在經皮給藥系統市場預測期間內，有哪些產品、細分市場、應用和領域需要考慮投資？

3.經皮給藥系統市場的技術趨勢和法規結構是什麼？

4.經皮給藥系統市場主要廠商的市場佔有率為何？

5. 進入經皮給藥系統市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病的流行和有效藥物傳遞的需求
      • 第三代經皮給藥系統的採用激增
    • 抑制因素
      • 擔心與貼片使用相關的刺激和皮膚敏感性
    • 機會
      • 經皮給藥系統的持續研究與開發
      • 製藥公司與 TDDS 供應商之間的無機成長策略
    • 任務
      • 經皮吸收系統和產品召回可能導致藥物失敗的風險
  • 市場區隔分析
    • 類型：經皮吸收貼片監管和政府核准正在進行中
    • 應用：心血管疾病管理對微創給藥系統的需求
    • 最終使用者：對自我給藥的偏好增加了對可在居家照護環境中實施的藥物輸送系統的需求。
  • 市場趨勢分析
    • 美洲地區的市場參與企業潛力和快速監管核准
    • 醫療費用快速上漲及外資進入亞太地區
    • 歐洲、中東和非洲地區持續的研究工作和慢性病負擔的增加。
    • 電子皮膚經皮革命
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析

第6章經皮給藥系統市場：依類型

  • 經皮吸收貼片
  • 經皮固態藥物

第7章經皮給藥系統市場：依應用

  • 心血管疾病
  • 中樞神經系統疾病
  • 荷爾蒙的應用
  • 疼痛管理
  • 經皮雌激素療法

第8章經皮給藥系統市場：依最終使用者分類

  • 居家照護設置
  • 醫院/診所

第9章北美及南美經皮給藥系統市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區經皮給藥系統市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲經皮給藥系統市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 魯永的每週兩次Rivastigmine經皮吸收貼片在中國核准用於治療阿茲海默症
    • Satio 贏得 350 萬美元契約，開發家用經皮給藥裝置
    • LTS 透過收購 Sorel 穿戴式注射設備業務完成聚合物藥物傳輸領域
    • DifGen Pharmaceuticals 收購 Aveva Drug Delivery Services Inc.
    • Zydus Lifesciences 獲得美國FDA 最終核准上市其雌二醇經皮吸收系統
    • Kindeva 與 Meridian 合併，創建專門從事製藥和醫療設備組合的全球 CDMO
    • LTS Roman主導投資專門從事無針分娩的公司
    • Love Pharma 收購經皮鴉片類藥物使用障礙藥物生產商
    • Corium為老年失智症失智症推出ADLARITY（多奈哌經皮吸收系統）
    • Lowenstein 代表 Pharma Tech LTS Lohmann Therapy Systems, Corp. 收購 Tapemark Inc.。

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-433C4187C49A

[180 Pages Report] The Transdermal Drug Delivery System Market size was estimated at USD 6.98 billion in 2023 and expected to reach USD 7.32 billion in 2024, at a CAGR 5.06% to reach USD 9.87 billion by 2030.

Transdermal drug delivery comprises the production, distribution, and application of therapeutic methods that facilitate the controlled release of medications through the skin. This innovative approach offers numerous advantages over conventional oral or intravenous drug administration, such as increased patient compliance, reduced side effects, and improved pharmacokinetic profiles. The TDDS encompasses various technologies, including passive diffusion systems, iontophoresis, microneedles, and ultrasound-mediated techniques. The increase in the aging population and the growing prevalence of chronic diseases necessitate more practical and convenient drug delivery methods. Furthermore, advancements in nanotechnology and materials science have enabled the development of sophisticated transdermal patches that offer superior drug permeation across biological membranes without causing irritation or discomfort to patients. However, high development costs associated with producing complex transdermal systems and incidences of product recalls may adversely impact their use in the healthcare sector. Besides, advanced drug delivery vehicles demonstrate promising potential to improve the bioavailability and solubility of water-soluble drugs, enabling more effective transdermal drug delivery strategies.

KEY MARKET STATISTICS
Base Year [2023] USD 6.98 billion
Estimated Year [2024] USD 7.32 billion
Forecast Year [2030] USD 9.87 billion
CAGR (%) 5.06%

Type: Ongoing regulatory and government approvals for transdermal patches

Transdermal patches are adhesive-coated, medicated patches designed to deliver a specific drug dosage through the skin and into the bloodstream over an extended period. They offer several advantages over conventional oral and parenteral drug delivery systems, such as improved patient compliance, reduced side effects, and controlled release of active ingredients. Drug-in-adhesive patches, matrix patches, microneedle patches, and reservoir membrane patches are available and are used according to medical requirements. The preference for transdermal patches is mainly due to their non-invasive nature and ease of application. They are suitable for patients experiencing difficulties swallowing pills or for those with gastrointestinal issues that may affect the absorption of medications. Transdermal semisolids include gels, creams, and ointments formulated with drugs that are absorbed through the skin into the systemic circulation. These dosage forms offer benefits such as easy application and removal, localized treatment without systemic side effects for certain conditions, and flexibility in formulation. Transdermal patches provide more consistent drug release than semisolids since they possess a controlled-release mechanism. Additionally, patches show better adhesion to the skin surface than semisolids, which may require frequent reapplication of the gels or creams.

Application: Need for minimally invasive drug delivery systems for management of cardiovascular diseases

Transdermal drug delivery systems are preferred in treating cardiovascular diseases such as angina pectoris or hypertension due to their ability to maintain constant plasma medication levels with fewer side effects. Nitroglycerin patches have been extensively used for angina patients, offering continuous relief without the need for frequent oral administration. TDDS displays an enhanced potential in managing central nervous system disorders, including Parkinson's disease and Alzheimer's disease, by maintaining steady concentrations of drugs. The continuous delivery minimizes fluctuations observed with oral medications, which can lead to breakthrough symptoms or side effects. Hormonal applications of TDDS include contraception, hormone replacement therapy (HRT), and testosterone supplementation. Transdermal patches offer advantages in maintaining steady hormone levels, reducing side effects, and improving patient compliance. Transdermal systems have gained popularity in managing chronic pain conditions, including musculoskeletal disorders or cancer-related pain, due to their ability to deliver analgesics directly to the affected area for long durations while minimizing systemic side effects. Transdermal estrogen therapy is essential for hormone replacement therapy for menopausal symptoms or osteoporosis management in postmenopausal women.

End-User: Preference for self-administration of drugs leading to demand for drug delivery systems that can be implemented in home care settings

Transdermal drug delivery systems are being utilized within particular innovative clinics for skin care and are implemented into the more effective health care system. With the growing understanding of drug delivery and the continued efforts of medical doctors, engineers, and scientists to advance this technology, an ultrasound-based transdermal delivery platform is expected to be a step closer to clinical applications. Clinical impact relies on a transdermal delivery system that administers drugs safely and effectively, is low-cost and easy to use, and is designed for self-administration at home. Transdermal drug delivery has recently gained popularity due to its unique and advantageous properties, which provide prospective benefits over conventional routes of drug administration in the therapy of numerous illnesses in hospital settings. Hospitals and clinics serve several patients in rural regions, particularly senior populations. These pharmacists help patients at a higher risk of medication interactions or illness complications due to a lack of control over their condition.

Regional Insights

The transdermal drug delivery market is evolving in the Americas due to its well-established healthcare infrastructure and research & development activities. Regulatory bodies in the Americas ensure adherence to standard guidelines while approving new products, resulting in the development of innovative transdermal technologies. The APAC region has a growing demand for advanced healthcare technologies due to increasing disposable incomes, population aging, and the need for efficient treatments. The transdermal drug delivery system market is growing in the EMEA region due to the presence of pharmaceutical industries, increased healthcare spending, and the rapid expansion of its manufacturing capabilities for transdermal systems. Moreover, the increasing adoption of personalized medicine and targeted therapies presents further prospects for TDDS systems tailored to specific patient populations or disease conditions.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Transdermal Drug Delivery System Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Transdermal Drug Delivery System Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Transdermal Drug Delivery System Market, highlighting leading vendors and their innovative profiles. These include 3M Company, AdhexPharma, SAS, Bayer AG, Biotts Inc., Boehringer Ingelheim International GmbH, DuPont de Nemours, Inc., Gensco Pharma, Hisamitsu Pharmaceutical Co., Inc., IBSA Farmaceutici Italia Srl, IntelGenx Corp., Johnson & Johnson Services, Inc., Kindeva Drug Delivery L.P., Lavipharm S.A., Lead Chemical Co., Ltd., Luye Life Sciences Group, Medherant Limited, Nitto Denko Corporation, Novartis International AG, Nutriband Inc., Purdue Pharma L.P., Sorrento Therapeutics, Inc., Sparsha Pharma International Pvt. Ltd., Starton Therapeutics, Toa Eiyo Ltd., Toyo Ink SC Holdings Co., Ltd., Transdermal Therapeutics, Inc., UCB S.A., Viatris Inc., Zhongshan Senwell Bio Technology Co., Ltd., and Zynerba Pharmaceuticals, Inc..

Market Segmentation & Coverage

This research report categorizes the Transdermal Drug Delivery System Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Transdermal Patches
      • Drug-In-Adhesive Patches
      • Matrix Patches
      • Microneedle Patches
      • Reservoir Membrane Patches
    • Transdermal Semisolids
      • Gels
      • Ointments
      • Sprays
  • Application
    • Cardiovascular Diseases
    • Central Nervous System Disorders
    • Hormonal Applications
    • Pain Management
    • Transdermal Estrogen Therapy
  • End User
    • Home Care Settings
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Transdermal Drug Delivery System Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Transdermal Drug Delivery System Market?

3. What are the technology trends and regulatory frameworks in the Transdermal Drug Delivery System Market?

4. What is the market share of the leading vendors in the Transdermal Drug Delivery System Market?

5. Which modes and strategic moves are suitable for entering the Transdermal Drug Delivery System Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic diseases and the need for effective drug delivery
      • 5.1.1.2. Surging adoption of third-generation transdermal drug delivery system
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns associated with irritation or skin sensitivity over patch usage
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research & development in transdermal drug delivery system
      • 5.1.3.2. Inorganic growth strategies between pharmaceutical companies and TDDS vendors
    • 5.1.4. Challenges
      • 5.1.4.1. Probable risk of drug failure through transdermal systems and product recalls
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Ongoing regulatory and government approvals for transdermal patches
    • 5.2.2. Application: Need for minimally invasive drug delivery systems for management of cardiovascular diseases
    • 5.2.3. End-User: Preference for self-administration of drugs leading to demand for drug delivery systems that can be implemented in home care settings
  • 5.3. Market Trend Analysis
    • 5.3.1. Potential power of market players and surge in regulatory approvals in the American region
    • 5.3.2. Surging healthcare spendings and inclusion of overseas players in the APAC region
    • 5.3.3. Persistent research activities and the growing burden of chronic disease in the EMEA region.
    • 5.3.4. Revolutionizing transdermal drug delivery with electronic skin
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis

6. Transdermal Drug Delivery System Market, by Type

  • 6.1. Introduction
  • 6.2. Transdermal Patches
  • 6.3. Transdermal Semisolids

7. Transdermal Drug Delivery System Market, by Application

  • 7.1. Introduction
  • 7.2. Cardiovascular Diseases
  • 7.3. Central Nervous System Disorders
  • 7.4. Hormonal Applications
  • 7.5. Pain Management
  • 7.6. Transdermal Estrogen Therapy

8. Transdermal Drug Delivery System Market, by End User

  • 8.1. Introduction
  • 8.2. Home Care Settings
  • 8.3. Hospitals & Clinics

9. Americas Transdermal Drug Delivery System Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Transdermal Drug Delivery System Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Transdermal Drug Delivery System Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Luye Pharma's Rivastigmine Twice Weekly Transdermal Patch Approved in China for the Treatment of Alzheimer's Disease
    • 12.3.2. Satio Wins USD 3.5 Million Contract To Develop At-Home Transdermal Drug Delivery Device
    • 12.3.3. LTS Completes Its Entry Into Large Molecule Drug Delivery With The Acquisition Of The Sorrel Wearable Injection Device Business
    • 12.3.4. DifGen Pharmaceuticals Acquires Aveva Drug Delivery Services Inc.
    • 12.3.5. Zydus Lifesciences gets Final Approval from the U.S. FDA to Market Estradiol Transdermal System
    • 12.3.6. Kindeva Merges with Meridian to Create Global CDMO Specializing in Drug-Device Combinations
    • 12.3.7. LTS Lohmann Leads Investment in Needle-Free Delivery Specialist
    • 12.3.8. Love Pharma Moves To Buy Transdermal Opioid-Use Disorder Player
    • 12.3.9. Corium Launches ADLARITY (donepezil transdermal system) for Patients with Alzheimer's Dementia
    • 12.3.10. Lowenstein Represents Pharma Tech LTS Lohmann Therapy Systems, Corp. in Acquisition of Tapemark Inc.

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET RESEARCH PROCESS
  • FIGURE 2. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET DYNAMICS
  • FIGURE 7. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY DRUG-IN-ADHESIVE PATCHES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MATRIX PATCHES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MATRIX PATCHES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRONEEDLE PATCHES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY MICRONEEDLE PATCHES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY RESERVOIR MEMBRANE PATCHES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY RESERVOIR MEMBRANE PATCHES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GELS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY GELS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY OINTMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY SPRAYS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY SPRAYS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HORMONAL APPLICATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HORMONAL APPLICATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL ESTROGEN THERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL ESTROGEN THERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 71. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 72. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 81. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 82. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 83. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2023 (USD MILLION)
  • TABLE 84. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2024-2030 (USD MILLION)
  • TABLE 85. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2023 (USD MILLION)
  • TABLE 86. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 89. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 90. CANADA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 91. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2023 (USD MILLION)
  • TABLE 94. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2024-2030 (USD MILLION)
  • TABLE 95. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2023 (USD MILLION)
  • TABLE 96. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2024-2030 (USD MILLION)
  • TABLE 97. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 98. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 99. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 100. MEXICO TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 101. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2024-2030 (USD MILLION)
  • TABLE 105. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2023 (USD MILLION)
  • TABLE 106. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 109. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 110. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 111. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 112. UNITED STATES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2024-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2023 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 126. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2023 (USD MILLION)
  • TABLE 128. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2024-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2023 (USD MILLION)
  • TABLE 130. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2024-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 132. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 134. AUSTRALIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 135. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2023 (USD MILLION)
  • TABLE 138. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2024-2030 (USD MILLION)
  • TABLE 139. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2023 (USD MILLION)
  • TABLE 140. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2024-2030 (USD MILLION)
  • TABLE 141. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 142. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 143. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 144. CHINA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 145. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2023 (USD MILLION)
  • TABLE 148. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2024-2030 (USD MILLION)
  • TABLE 149. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2023 (USD MILLION)
  • TABLE 150. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2024-2030 (USD MILLION)
  • TABLE 151. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 152. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 153. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 154. INDIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 155. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2023 (USD MILLION)
  • TABLE 158. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2024-2030 (USD MILLION)
  • TABLE 159. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2023 (USD MILLION)
  • TABLE 160. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2024-2030 (USD MILLION)
  • TABLE 161. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 164. INDONESIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 165. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2023 (USD MILLION)
  • TABLE 168. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2024-2030 (USD MILLION)
  • TABLE 169. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2023 (USD MILLION)
  • TABLE 170. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2024-2030 (USD MILLION)
  • TABLE 171. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 172. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 173. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 174. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 175. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2023 (USD MILLION)
  • TABLE 178. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2024-2030 (USD MILLION)
  • TABLE 179. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2023 (USD MILLION)
  • TABLE 180. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2024-2030 (USD MILLION)
  • TABLE 181. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 182. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 183. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 184. MALAYSIA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 186. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2023 (USD MILLION)
  • TABLE 188. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2024-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2023 (USD MILLION)
  • TABLE 190. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2024-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 192. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 193. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 194. PHILIPPINES TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 195. SINGAPORE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. SINGAPORE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. SINGAPORE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2023 (USD MILLION)
  • TABLE 198. SINGAPORE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2024-2030 (USD MILLION)
  • TABLE 199. SINGAPORE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2023 (USD MILLION)
  • TABLE 200. SINGAPORE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2024-2030 (USD MILLION)
  • TABLE 201. SINGAPORE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 202. SINGAPORE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 203. SINGAPORE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 204. SINGAPORE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 206. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2023 (USD MILLION)
  • TABLE 208. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2024-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2023 (USD MILLION)
  • TABLE 210. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2024-2030 (USD MILLION)
  • TABLE 211. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 212. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 213. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 214. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 215. TAIWAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 216. TAIWAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 217. TAIWAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2023 (USD MILLION)
  • TABLE 218. TAIWAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2024-2030 (USD MILLION)
  • TABLE 219. TAIWAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2023 (USD MILLION)
  • TABLE 220. TAIWAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2024-2030 (USD MILLION)
  • TABLE 221. TAIWAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 222. TAIWAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 223. TAIWAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 224. TAIWAN TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 225. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2023 (USD MILLION)
  • TABLE 228. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2024-2030 (USD MILLION)
  • TABLE 229. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2023 (USD MILLION)
  • TABLE 230. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2024-2030 (USD MILLION)
  • TABLE 231. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 232. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 233. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 234. THAILAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 235. VIETNAM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. VIETNAM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. VIETNAM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2023 (USD MILLION)
  • TABLE 238. VIETNAM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2024-2030 (USD MILLION)
  • TABLE 239. VIETNAM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2023 (USD MILLION)
  • TABLE 240. VIETNAM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2024-2030 (USD MILLION)
  • TABLE 241. VIETNAM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 242. VIETNAM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 243. VIETNAM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 244. VIETNAM TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2024-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2023 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 257. DENMARK TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 258. DENMARK TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 259. DENMARK TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2023 (USD MILLION)
  • TABLE 260. DENMARK TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2024-2030 (USD MILLION)
  • TABLE 261. DENMARK TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2023 (USD MILLION)
  • TABLE 262. DENMARK TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2024-2030 (USD MILLION)
  • TABLE 263. DENMARK TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 264. DENMARK TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 265. DENMARK TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 266. DENMARK TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 267. EGYPT TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. EGYPT TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. EGYPT TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2023 (USD MILLION)
  • TABLE 270. EGYPT TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2024-2030 (USD MILLION)
  • TABLE 271. EGYPT TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2023 (USD MILLION)
  • TABLE 272. EGYPT TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2024-2030 (USD MILLION)
  • TABLE 273. EGYPT TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 274. EGYPT TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 275. EGYPT TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 276. EGYPT TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 277. FINLAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 278. FINLAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 279. FINLAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2023 (USD MILLION)
  • TABLE 280. FINLAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2024-2030 (USD MILLION)
  • TABLE 281. FINLAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2023 (USD MILLION)
  • TABLE 282. FINLAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2024-2030 (USD MILLION)
  • TABLE 283. FINLAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 284. FINLAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 285. FINLAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 286. FINLAND TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 287. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 288. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 289. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2023 (USD MILLION)
  • TABLE 290. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2024-2030 (USD MILLION)
  • TABLE 291. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2018-2023 (USD MILLION)
  • TABLE 292. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL SEMISOLIDS, 2024-2030 (USD MILLION)
  • TABLE 293. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 294. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 295. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 296. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 297. GERMANY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 298. GERMANY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 299. GERMANY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2018-2023 (USD MILLION)
  • TABLE 300. GERMANY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL PATCHES, 2024-2030 (USD MILLION)
  • TABLE 301. GERMANY TRANSDERMAL DRUG DELIVERY SYSTEM MARKET SIZE, BY TRANSDERMAL